{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T07:13:07Z","timestamp":1793257987104,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","cghjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.cgh.2023.04.031","type":"journal-article","created":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T16:45:19Z","timestamp":1683737119000},"page":"3125-3131.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Bile Acid Sequestrants in Microscopic Colitis: Clinical Outcomes and Utility of Bile Acid Testing"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9914-1695","authenticated-orcid":false,"given":"June","family":"Tome","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanika","family":"Sehgal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrit K.","family":"Kamboj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William S.","family":"Harmsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahil","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darrell S.","family":"Pardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2023.04.031_bib1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/ajg.2014.431","article-title":"Incidence, prevalence, and temporal trends of microscopic colitis: a systematic review and meta-analysis","volume":"110","author":"Tong","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2023.04.031_bib2","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.cgh.2021.06.027","article-title":"The epidemiology of microscopic colitis in Olmsted County, Minnesota: population-based study from 2011 to 2019","volume":"20","author":"Tome","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2023.04.031_bib3","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/ajg.2016.477","article-title":"Diagnosis and management of microscopic colitis","volume":"112","author":"Pardi","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2023.04.031_bib4","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000071","article-title":"Long-term natural history of microscopic colitis: a population-based cohort","volume":"10","author":"Loreau","year":"2019","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.cgh.2023.04.031_bib5","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/ajg.2012.416","article-title":"Outcomes of patients with microscopic colitis treated with corticosteroids: a population-based study","volume":"108","author":"Gentile","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2023.04.031_bib6","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.14309\/ajg.0000000000001774","article-title":"Budesonide maintenance in microscopic colitis: clinical outcomes and safety profile from a population-based study","volume":"117","author":"Tome","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2023.04.031_bib7","first-page":"432","article-title":"Role of bile acids in lymphocytic colitis","volume":"49","author":"Ung","year":"2002","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.cgh.2023.04.031_bib8","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000481197","article-title":"Farnesoid X receptor expression in microscopic colitis: a potential role in disease etiopathogenesis","volume":"25","author":"Torres","year":"2018","journal-title":"GE Port J Gastroenterol"},{"key":"10.1016\/j.cgh.2023.04.031_bib9","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.3390\/nu14132664","article-title":"Bile acid-related regulation of mucosal inflammation and intestinal motility: from pathogenesis to therapeutic application in IBD and microscopic colitis","volume":"14","author":"Di Vincenzo","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.cgh.2023.04.031_bib10","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/BF01395507","article-title":"Dose-related effects of chenodeoxycholic acid in the rabbit colon","volume":"25","author":"Camilleri","year":"1980","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2023.04.031_bib11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/MCG.0000000000001496","article-title":"Bile acid sequestrant therapy in microscopic colitis","volume":"56","author":"Northcutt","year":"2022","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2023.04.031_bib12","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/003655201750163033","article-title":"Long-term course in collagenous colitis and the impact of bile acid malabsorption and bile acid sequestrants on histopathology and clinical features","volume":"36","author":"Ung","year":"2001","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2023.04.031_bib13","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1111\/j.1365-2036.2006.03168.x","article-title":"Budesonide treatment is associated with increased bile acid absorption in collagenous colitis","volume":"24","author":"Bajor","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2023.04.031_bib14","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1097\/00054725-200608000-00006","article-title":"Microscopic colitis is not associated with cholecystectomy or appendectomy","volume":"12","author":"Laing","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2023.04.031_bib15","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1023\/A:1011927302076","article-title":"Bile acid malabsorption in microscopic colitis and in previously unexplained functional chronic diarrhea","volume":"46","author":"Fern\u00e1ndez-Ba\u00f1ares","year":"2001","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2023.04.031_bib16","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1136\/gut.46.2.170","article-title":"Role of bile acids and bile acid binding agents in patients with collagenous colitis","volume":"46","author":"Ung","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2023.04.031_bib17","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1053\/j.gastro.2015.11.008","article-title":"Clinical Guidelines Committee. American Gastroenterological Association Institute Guideline on the Medical Management of Microscopic Colitis","volume":"150","author":"Nguyen","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2023.04.031_bib18","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/MEG.0000000000001456","article-title":"Budesonide treatment for microscopic colitis: systematic review and meta-analysis","volume":"31","author":"Sebastian","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2023.04.031_bib19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/gutjnl-2014-308363","article-title":"BUC-63 investigators. Low-dose budesonide for maintenance of clinical remission in collagenous colitis: a randomized, placebo-controlled, 12-month trial","volume":"65","author":"M\u00fcnch","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2023.04.031_bib20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/2050640620951905","article-title":"European Guidelines on microscopic colitis: United European Gastroenterology and European Microscopic Colitis Group statements and recommendations","volume":"9","author":"Miehlke","year":"2021","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.cgh.2023.04.031_bib21","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12876-019-1102-1","article-title":"Methods for diagnosing bile acid malabsorption: a systematic review","volume":"19","author":"Lyutakov","year":"2019","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.cgh.2023.04.031_bib22","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1053\/j.gastro.2018.11.069","article-title":"Current practice in the diagnosis of bile acid diarrhea","volume":"156","author":"Vijayvargiya","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2023.04.031_bib23","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.14309\/ajg.0000000000000696","article-title":"The role of bile acids in chronic diarrhea","volume":"115","author":"Camilleri","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2023.04.031_bib24","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1002\/ibd.20977","article-title":"Defining clinical criteria for clinical remission and disease activity in collagenous colitis","volume":"15","author":"Hjortswang","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2023.04.031_bib25","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/apt.16594","article-title":"Medication use and microscopic colitis","volume":"54","author":"Sandler","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2023.04.031_bib26","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1007\/s10620-021-06993-5","article-title":"Increased fecal bile acid excretion in a significant subset of patients with other inflammatory diarrheal diseases","volume":"67","author":"Vijayvargiya","year":"2022","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2023.04.031_bib27","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/j.1440-1746.2006.04511.x","article-title":"Mesalazine with or without cholestyramine in the treatment of microscopic colitis: randomized controlled trial","volume":"22","author":"Calabrese","year":"2007","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2023.04.031_bib28","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1053\/j.gastro.2018.08.042","article-title":"efficacy and safety of budesonide, vs. mesalazine or placebo, as induction therapy\u00a0for lymphocytic colitis","volume":"55","author":"Miehlke","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2023.04.031_bib29","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1053\/j.gastro.2014.01.019","article-title":"Budesonide is more\u00a0effective than mesalamine or placebo in short-term treatment of collagenous colitis","volume":"146","author":"Miehlke","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2023.04.031_bib30","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2147\/CEG.S165047","article-title":"Management of microscopic colitis: challenges and solutions","volume":"12","author":"Shor","year":"2019","journal-title":"Clin Exp Gastroenterol"},{"key":"10.1016\/j.cgh.2023.04.031_bib31","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/MEG.0000000000001925","article-title":"Serum 7-alfa-hydroxy-4-cholesten-3-one and fibroblast growth factor-19 as biomarkers diagnosing bile acid malabsorption in microscopic colitis and inflammatory bowel disease","volume":"33","author":"Lyutakov","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356523003312?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356523003312?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T06:38:39Z","timestamp":1731739119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356523003312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S1542356523003312"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2023.04.031","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bile Acid Sequestrants in Microscopic Colitis: Clinical Outcomes and Utility of Bile Acid Testing","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2023.04.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the AGA Institute","name":"copyright","label":"Copyright"}]}}